(AAO) Study confirms Phase III results for uveitis treatment
November 14th 2020Glenn J. Jaffe, MD, presents a summary of the results of a confirmatory study on a previous Phase III trial that examined sustained drug delivery for the treatment of uveitis, as well as data on the 36-month results in the second, confirmatory phase 3 study of YUTIQ.
Read More
(AAO) Bringing high-level content to a virtual audience
November 13th 2020Anne L. Coleman, MD, president of the American Academy of Ophthalmology, offers a preview of its virtual 2020 annual meeting. The AAO is rising to meet the challenges of staging a large-scale event in a virtual setting.
Read More
Medical professionals urge Congress to retain Medicare sequester pause
October 27th 2020Congress paused Medicare sequester cuts to offer relief amid the pandemic. Now, the leaders of the American Medical Association, American Hospital Association, American Health Care Association, and National Association for Home Care & Hospice are urging congressional leadership to keep the pause in place.
Read More
COVID-19: Practices falling short of pre-pandemic levels
October 2nd 2020Primary care has yet to regain the strength it had before the COVID-19 pandemic, according to a study released recently by the Larry A. Green Center, a research organization, in collaboration with the Primary Care Collaborative.
Read More
Tattoo you: Scleral tattoos pose threat to eye health
September 29th 2020A French kindergarten teacher has lost his job after the parents of a child complained about his appearance, which includes multiple face tattoos, including the sclera of his eyes, which have been turned to black by the ink. Scleral tattoos pose a serious threat to eye health, and could be a challenge for ophthalmologists treating these patients.
Read More
COVID-19 pandemic driving jump in Medicaid enrollment
September 9th 2020According to an analysis of Medicaid enrollment data during the coronavirus disease 2019 (COVID-19) pandemic, there has been an increase in enrollment during the crisis. This shift is likely to have a ripple effect throughout the healthcare landscape, including ophthalmology.
Read More
Survey: Pandemic could leave children with less access to ophthalmologists
September 5th 2020A survey by the American Association of Pediatric Ophthalmology and Strabismus found that the COVID-19 pandemic could leave some pediatric ophthalmology practices highly strained, possibly beyond repair.
Read More
Researchers developing antiviral drug for COVID-19
August 31st 2020Investigators with the Texas Tech University Health Sciences Center Department of Ophthalmology and Visual Sciences have filed a US patent for a novel peptide that uses selenium as a catalyst to target vulnerable areas of coronaviruses, including COVID-19.
Read More
FDA grants fourth ODD for treatment of gene mutation-associated retinal diseases
August 12th 2020The FDA this week granted the fourth Orphan Drug Designation for a novel gene therapy product candidate (OCU400, Ocugen Inc.) in the treatment of PDE6B gene mutation-associated retinal diseases.
Read More
Evaluating 3-year recurrence rate in non-infectious posterior segment uveitis post-FAi
August 11th 2020Dilraj Grewal, MD, speaks on his presentation "Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis Following an Injectable Fluocinolone Acetonide Insert," during ASRS 2020.
Read More
Study: Asymptomatic COVID-19 patients may have left viral material on surfaces of exam room
August 10th 2020A team of Turkish investigators detected COVID-19 viral material on the environmental surfaces of an ophthalmology examination room despite triage systems to exclude patients with the virus.
Read More